WAS and essential thrombocythemia: A recent study in class prediction models of ET included a member from this family (WASF3) as one of the biomarkers segregating ET from reactive thrombocytosis and healthy controls [24], thereby extending the role of the WAS family of proteins in key regulatory functions of megakaryocytopoiesis and/or platelet activation.